Cargando…
PI3K Signaling in Mechanisms and Treatments of Pulmonary Fibrosis Following Sepsis and Acute Lung Injury
Pulmonary fibrosis is a pathological fibrotic process affecting the lungs of five million people worldwide. The incidence rate will increase even more in the next years due to the long-COVID-19 syndrome, but a resolving treatment is not available yet and usually prognosis is poor. The emerging role...
Autores principales: | Margaria, Jean Piero, Moretta, Lucia, Alves-Filho, Jose Carlos, Hirsch, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028704/ https://www.ncbi.nlm.nih.gov/pubmed/35453505 http://dx.doi.org/10.3390/biomedicines10040756 |
Ejemplares similares
-
The Guareschi Pyridine Scaffold as a Valuable Platform for the Identification of Selective PI3K Inhibitors
por: Galli, Ubaldina, et al.
Publicado: (2015) -
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis
por: Campa, Carlo C., et al.
Publicado: (2018) -
Class II PI3Ks at the Intersection between Signal Transduction and Membrane Trafficking
por: Margaria, Jean Piero, et al.
Publicado: (2019) -
TILRR Aggravates Sepsis-Induced Acute Lung Injury by Suppressing the PI3K/Akt Pathway
por: Wang, Xiaoyu, et al.
Publicado: (2022) -
Tryptase is involved in the development of early ventilator-induced pulmonary fibrosis in sepsis-induced lung injury
por: Villar, Jesús, et al.
Publicado: (2015)